Amy H Tang received a BS in Biophysics from Fudan University, and a PhD in Biochemistry and Molecular Biology from Pennsylvania State University. She completed her Post-doctoral training supported by two Post-doctoral fellowships, (1) NIH Post-doctoral fellowship and (2) Leukemia and Lymphomia Society (LSA) Senior Post-doctoral Fellowship at UC Berkeley. She is a Professor of Cancer Biology at Eastern Virginia Medical School. She is a lead Pancreatic Cancer Researcher and a Recipient of the highly prestigeous national cancer award – 2010 AACR-PanCAN Innovative Award. She and her research team have developed an innovative strategy and therapy-responsive prognostic biomarkers to control and eradiacte oncogenic K-RAS-driven pancreatic cancer in preclinical and clinical settings. She has published numerous papers in peer-reviewed journals, and secured NIH/DOD/AACR-pancreatic cancer action network innovative grant/ lustgarden foundation for pancreatic cancer research. She has served as reviewers at multiple NIH study sections for more than 10 years, and has served as the Editorial Advisory Board Member and reviewer of numerous scientfic journals. Amy H Tang received a BS in Biophysics from Fudan University, and a PhD in Biochemistry and Molecular Biology from Pennsylvania State University. She completed her Post-doctoral training supported by two Post-doctoral fellowships, (1) NIH Post-doctoral fellowship and (2) Leukemia and Lymphomia Society (LSA) Senior Post-doctoral Fellowship at UC Berkeley. She is a Professor of Cancer Biology at Eastern Virginia Medical School. She is a lead Pancreatic Cancer Researcher and a Recipient of the highly prestigeous national cancer award – 2010 AACR-PanCAN Innovative Award. She and her research team have developed an innovative strategy and therapy-responsive prognostic biomarkers to control and eradiacte oncogenic K-RAS-driven pancreatic cancer in preclinical and clinical settings. She has published numerous papers in peer-reviewed journals, and secured NIH/DOD/AACR-pancreatic cancer action network innovative grant/ lustgarden foundation for pancreatic cancer research. She has served as reviewers at multiple NIH study sections for more than 10 years, and has served as the Editorial Advisory Board Member and reviewer of numerous scientfic journals.

Gastroenterology